Table 1.

Baseline characteristics

Baseline Characteristics	Total (N = 13)
Age, years ± SD	58 ± 10
Males, n (%)	11 (85)
Whites, n (%)	13 (100)
History of extracardiac sarcoidosis, n (%)	10 (77)
Immunosuppression therapy at time of FDG, n (%)	4 (31)
Immunosuppression therapy at time of Dotatate, n (%)	5 (38)
Left ventricular ejection fraction, % ± SD	59 ± 15
LVEF < 50%, n (%)	3 (23)
Implantable cardioverter defibrillator/pacemaker, n (%)	8 (61)
Hight degree atria-ventricular block, n (%)	4 (31)
Ventricular tachycardia, n (%)	2 (15)
Dyspnea, n (%)	6 (46)
Near syncope, n (%)	1 (8)